0001745020-23-000060.txt : 20231107 0001745020-23-000060.hdr.sgml : 20231107 20231107160337 ACCESSION NUMBER: 0001745020-23-000060 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231106 FILED AS OF DATE: 20231107 DATE AS OF CHANGE: 20231107 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shakespeare William CENTRAL INDEX KEY: 0001879255 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40869 FILM NUMBER: 231383597 MAIL ADDRESS: STREET 1: 245 MAIN STREET, 2ND FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Theseus Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001745020 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 830712806 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 314 MAIN STREET, SUITE 04-200 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: (857) 400-9491 MAIL ADDRESS: STREET 1: 314 MAIN STREET, SUITE 04-200 CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 wk-form4_1699391003.xml FORM 4 X0508 4 2023-11-06 0 0001745020 Theseus Pharmaceuticals, Inc. THRX 0001879255 Shakespeare William C/O THESEUS PHARMACEUTICALS, INC. 314 MAIN STREET CAMBRIDGE MA 02142 0 1 0 0 See Remarks 0 Common Stock 2023-11-06 4 M 0 251084 0.32 A 639408 D Stock Option (right to buy) 0.32 2023-11-06 4 M 0 251084 0 D 2030-12-23 Common Stock 251084 93260 D The options are immediately exercisable in full due to early exercise rights, subject to the issuer's right of repurchase. The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period with 1/48th of the options vesting monthly after November 18, 2020, subject to the Reporting Person's continuous service with the issuer. President of Research and Development /s/ Bradford Dahms - Attorney-in-Fact 2023-11-07